AstraZeneca

AstraZeneca is a pharmaceutical and biotechnology company based in the United Kingdom. In the battle against COVID-19, Astrazeneca is one of the top five companies in the world, and they are beginning Phase III studies in conjunction with the University of Oxford.

Their mission is to push science's frontiers in order to develop life-changing treatments. They think that putting research at the core of all they do is the greatest approach to achieve their Purpose. They are defined by science. It is part of our DNA and why they come to work every day. This, however, is only half of the tale. They are well aware that they do not possess all of the solutions. They want to share their thoughts because they feel it will lead to improved treatments. They aim to operate in a way that is welcoming, open, and collaborative. This mindset pervades all they do.

They are selectively active in the areas of autoimmune, neurology, and infection, and focus on three key therapeutic areas: oncology, cardiovascular and metabolic disease (CVMD), and respiratory disease. They want to use our mix of strengths, which include small molecules and biologics, immunotherapies, and inventing new delivery systems that provide patients a choice, to put us in the greatest position to push the limits of science. These are bolstered by a significant focus on customized healthcare capabilities, which try to match medications to just those patients who would benefit. Their teams also collaborate with some of the world's most prestigious academic and biotech research institutes to foster innovation and assess new technologies like modified RNA and CRISPR genome editing.

Founded: April 6, 1999
Market Cap: 181.450 Billion USD

Headquarters: Cambridge, United Kingdom

Website: https://www.astrazeneca-us.com/